Annual EBIT
-$15.14 M
+$3.73 M+19.75%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual earnings before interest & taxes is -$15.14 million, with the most recent change of +$3.73 million (+19.75%) on December 1, 2023.
- During the last 3 years, BRTX annual EBIT has fallen by -$5.50 million (-57.15%).
- BRTX annual EBIT is now -631.52% below its all-time high of -$2.07 million, reached on December 31, 2010.
Performance
BRTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.29 M
+$181.80 K+7.36%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly earnings before interest & taxes is -$2.29 million, with the most recent change of +$181.80 thousand (+7.36%) on September 1, 2024.
- Over the past year, BRTX quarterly EBIT has increased by +$734.10 thousand (+24.30%).
- BRTX quarterly EBIT is now -178.87% below its all-time high of $2.90 million, reached on June 30, 2020.
Performance
BRTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$12.09 M
+$734.10 K+5.73%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM earnings before interest & taxes is -$12.09 million, with the most recent change of +$734.10 thousand (+5.73%) on September 1, 2024.
- Over the past year, BRTX TTM EBIT has increased by +$4.42 million (+26.77%).
- BRTX TTM EBIT is now -3164.67% below its all-time high of -$370.20 thousand, reached on September 30, 2010.
Performance
BRTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BRTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.8% | +24.3% | +26.8% |
| 3 y3 years | -57.1% | +43.0% | +54.1% |
| 5 y5 years | -62.8% | +43.0% | +54.1% |
BRTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.5% | at high | +60.4% | at high | +54.1% |
| 5 y | 5-year | -59.2% | +42.5% | -178.9% | +84.8% | -153.6% | +56.6% |
| alltime | all time | -631.5% | +42.5% | -178.9% | +84.8% | -3164.7% | +56.6% |
BioRestorative Therapies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.29 M(-7.4%) | -$12.09 M(-5.7%) |
| Jun 2024 | - | -$2.47 M(-39.9%) | -$12.82 M(-4.8%) |
| Mar 2024 | - | -$4.11 M(+27.6%) | -$13.47 M(-11.0%) |
| Dec 2023 | -$15.14 M(-19.8%) | -$3.22 M(+6.6%) | -$15.14 M(-8.3%) |
| Sep 2023 | - | -$3.02 M(-3.1%) | -$16.50 M(-8.8%) |
| Jun 2023 | - | -$3.12 M(-46.1%) | -$18.09 M(-7.7%) |
| Mar 2023 | - | -$5.78 M(+26.0%) | -$19.61 M(+3.9%) |
| Dec 2022 | -$18.86 M(-28.3%) | -$4.59 M(-0.5%) | -$18.86 M(+3.2%) |
| Sep 2022 | - | -$4.61 M(-0.4%) | -$18.28 M(+5.3%) |
| Jun 2022 | - | -$4.63 M(-8.1%) | -$17.36 M(+6.6%) |
| Mar 2022 | - | -$5.04 M(+25.6%) | -$16.29 M(-38.1%) |
| Dec 2021 | -$26.31 M(+173.1%) | -$4.01 M(+8.7%) | -$26.31 M(-5.5%) |
| Sep 2021 | - | -$3.69 M(+3.8%) | -$27.83 M(+11.6%) |
| Jun 2021 | - | -$3.56 M(-76.4%) | -$24.94 M(+34.9%) |
| Mar 2021 | - | -$15.05 M(+172.1%) | -$18.48 M(+92.0%) |
| Dec 2020 | -$9.63 M(+1.3%) | -$5.53 M(+597.2%) | -$9.63 M(+102.0%) |
| Sep 2020 | - | -$793.70 K(-127.4%) | -$4.77 M(-33.3%) |
| Jun 2020 | - | $2.90 M(-146.8%) | -$7.15 M(-44.5%) |
| Mar 2020 | - | -$6.20 M(+820.9%) | -$12.88 M(+35.5%) |
| Dec 2019 | -$9.51 M(+2.3%) | -$673.10 K(-78.8%) | -$9.51 M(-18.8%) |
| Sep 2019 | - | -$3.17 M(+11.9%) | -$11.72 M(+9.8%) |
| Jun 2019 | - | -$2.84 M(+0.5%) | -$10.67 M(+6.3%) |
| Mar 2019 | - | -$2.82 M(-2.0%) | -$10.03 M(+7.9%) |
| Dec 2018 | -$9.30 M(+11.2%) | -$2.88 M(+35.5%) | -$9.30 M(+18.1%) |
| Sep 2018 | - | -$2.13 M(-3.4%) | -$7.87 M(+4.6%) |
| Jun 2018 | - | -$2.20 M(+5.6%) | -$7.52 M(-4.6%) |
| Mar 2018 | - | -$2.08 M(+43.1%) | -$7.89 M(-5.6%) |
| Dec 2017 | -$8.36 M | -$1.46 M(-18.1%) | -$8.36 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$1.78 M(-30.8%) | -$8.78 M(+0.4%) |
| Jun 2017 | - | -$2.57 M(+0.5%) | -$8.74 M(+5.0%) |
| Mar 2017 | - | -$2.56 M(+36.2%) | -$8.32 M(+5.7%) |
| Dec 2016 | -$7.87 M(+7.5%) | -$1.88 M(+7.7%) | -$7.87 M(-9.7%) |
| Sep 2016 | - | -$1.74 M(-18.9%) | -$8.72 M(+2.3%) |
| Jun 2016 | - | -$2.15 M(+1.9%) | -$8.52 M(+10.2%) |
| Mar 2016 | - | -$2.11 M(-22.6%) | -$7.73 M(+5.6%) |
| Dec 2015 | -$7.32 M(+38.1%) | -$2.72 M(+76.4%) | -$7.32 M(+21.6%) |
| Sep 2015 | - | -$1.54 M(+13.5%) | -$6.02 M(+9.4%) |
| Jun 2015 | - | -$1.36 M(-19.8%) | -$5.50 M(+1.8%) |
| Mar 2015 | - | -$1.70 M(+19.5%) | -$5.40 M(+1.9%) |
| Dec 2014 | -$5.30 M(-1.4%) | -$1.42 M(+38.4%) | -$5.30 M(-2.3%) |
| Sep 2014 | - | -$1.03 M(-18.6%) | -$5.43 M(-3.9%) |
| Jun 2014 | - | -$1.26 M(-21.0%) | -$5.65 M(+0.7%) |
| Mar 2014 | - | -$1.60 M(+3.3%) | -$5.61 M(+4.2%) |
| Dec 2013 | -$5.38 M(-9.5%) | -$1.55 M(+24.0%) | -$5.38 M(-9.0%) |
| Sep 2013 | - | -$1.25 M(+2.3%) | -$5.91 M(+0.7%) |
| Jun 2013 | - | -$1.22 M(-10.9%) | -$5.87 M(-4.3%) |
| Mar 2013 | - | -$1.37 M(-34.1%) | -$6.13 M(+0.0%) |
| Dec 2012 | -$5.94 M(+55.9%) | -$2.08 M(+72.3%) | -$6.13 M(+30.6%) |
| Sep 2012 | - | -$1.21 M(-18.7%) | -$4.70 M(+6.0%) |
| Jun 2012 | - | -$1.48 M(+8.4%) | -$4.43 M(+8.2%) |
| Mar 2012 | - | -$1.37 M(+113.4%) | -$4.09 M(+7.3%) |
| Dec 2011 | -$3.81 M(+84.3%) | -$640.80 K(-31.7%) | -$3.81 M(-12.3%) |
| Sep 2011 | - | -$938.40 K(-18.1%) | -$4.35 M(+15.0%) |
| Jun 2011 | - | -$1.15 M(+5.3%) | -$3.78 M(+43.5%) |
| Mar 2011 | - | -$1.09 M(-7.5%) | -$2.64 M(+70.4%) |
| Dec 2010 | -$2.07 M | -$1.18 M(+217.8%) | -$1.55 M(+317.8%) |
| Sep 2010 | - | -$370.20 K | -$370.20 K |
FAQ
- What is BioRestorative Therapies annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioRestorative Therapies?
- What is BioRestorative Therapies annual EBIT year-on-year change?
- What is BioRestorative Therapies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly EBIT year-on-year change?
- What is BioRestorative Therapies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioRestorative Therapies?
- What is BioRestorative Therapies TTM EBIT year-on-year change?
What is BioRestorative Therapies annual earnings before interest & taxes?
The current annual EBIT of BRTX is -$15.14 M
What is the all time high annual EBIT for BioRestorative Therapies?
BioRestorative Therapies all-time high annual earnings before interest & taxes is -$2.07 M
What is BioRestorative Therapies annual EBIT year-on-year change?
Over the past year, BRTX annual earnings before interest & taxes has changed by +$3.73 M (+19.75%)
What is BioRestorative Therapies quarterly earnings before interest & taxes?
The current quarterly EBIT of BRTX is -$2.29 M
What is the all time high quarterly EBIT for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly earnings before interest & taxes is $2.90 M
What is BioRestorative Therapies quarterly EBIT year-on-year change?
Over the past year, BRTX quarterly earnings before interest & taxes has changed by +$734.10 K (+24.30%)
What is BioRestorative Therapies TTM earnings before interest & taxes?
The current TTM EBIT of BRTX is -$12.09 M
What is the all time high TTM EBIT for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM earnings before interest & taxes is -$370.20 K
What is BioRestorative Therapies TTM EBIT year-on-year change?
Over the past year, BRTX TTM earnings before interest & taxes has changed by +$4.42 M (+26.77%)